Cetera Advisor Networks LLC Crispr Therapeutics Ag Transaction History

Cetera Advisor Networks LLC

$0
Q1 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$60.67 - $89.12 $8,190 - $12,031	-135 Reduced 0.6%	22,209 $1.51 Million
Q4 2023 Feb 13, 2024	BUY	$38.62 - $72.18 $500,940 - $936,246	12,971 Added 138.39%	22,344 $1.4 Million
Q3 2023 Nov 14, 2023	BUY	$45.39 - $59.0 $103,216 - $134,166	2,274 Added 32.03%	9,373 $425,000
Q2 2023 Aug 09, 2023	SELL	$43.47 - $67.77 $1,521 - $2,371	-35 Reduced 0.49%	7,099 $398,000
Q1 2023 May 15, 2023	SELL	$41.0 - $56.12 $16,564 - $22,672	-404 Reduced 5.36%	7,134 $322,000
Q4 2022 Feb 14, 2023	BUY	$39.19 - $65.67 $11,992 - $20,095	306 Added 4.23%	7,538 $306,000
Q3 2022 Nov 10, 2022	SELL	$61.1 - $83.78 $42,770 - $58,646	-700 Reduced 8.83%	7,232 $473,000
Q2 2022 Aug 11, 2022	SELL	$43.23 - $73.83 $23,776 - $40,606	-550 Reduced 6.48%	7,932 $482,000
Q1 2022 May 12, 2022	BUY	$53.19 - $79.24 $125,900 - $187,561	2,367 Added 38.71%	8,482 $532,000
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $323,675 - $513,937	-4,618 Reduced 43.03%	6,115 $463,000
Q3 2021 Nov 16, 2021	BUY	$110.2 - $156.64 $748,147 - $1.06 Million	6,789 Added 172.13%	10,733 $1.2 Million
Q2 2021 Aug 13, 2021	BUY	$100.84 - $161.89 $94,587 - $151,852	938 Added 31.2%	3,944 $638,000
Q1 2021 May 17, 2021	SELL	$110.72 - $210.04 $255,873 - $485,402	-2,311 Reduced 43.46%	3,006 $366,000
Q4 2020 Feb 17, 2021	SELL	$79.67 - $173.23 $92,895 - $201,986	-1,166 Reduced 17.99%	5,317 $814,000
Q3 2020 Nov 13, 2020	SELL	$78.5 - $100.64 $1,570 - $2,012	-20 Reduced 0.31%	6,483 $542,000
Q2 2020 Aug 13, 2020	BUY	$38.5 - $76.05 $67,413 - $133,163	1,751 Added 36.85%	6,503 $478,000
Q1 2020 May 08, 2020	SELL	$33.68 - $62.53 $27,651 - $51,337	-821 Reduced 14.73%	4,752 $202,000
Q4 2019 Feb 10, 2020	BUY	$36.68 - $73.13 $204,417 - $407,553	5,573 New	5,573 $341,000
Q3 2019 Nov 06, 2019	SELL	$40.99 - $52.56 $194,415 - $249,292	-4,743 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$35.45 - $48.2 $168,139 - $228,612	4,743 New	4,743 $222,000
Q4 2018 Feb 15, 2019	SELL	$22.73 - $42.34 $269,873 - $502,702	-11,873 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$44.35 - $65.71 $123,869 - $183,528	2,793 Added 30.76%	11,873 $523,000
Q2 2018 Aug 14, 2018	BUY	$42.62 - $73.59 $386,989 - $668,197	9,080 New	9,080 $536,000

Others Institutions Holding CRSP

# of Institutions

484

Shares Held

64.1M

Call Options Held

1.64M

Put Options Held

1.93M

Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl

8.97M
Shares

$453 Million
3.09% of portfolio
Capital International Investors Los Angeles, CA

8.74M
Shares

$441 Million
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

3.81M
Shares

$192 Million
0.09% of portfolio
Black Rock Inc. New York, NY

2.78M
Shares

$140 Million
0.0% of portfolio
Sumitomo Mitsui Trust Holdings, Inc.

2.75M
Shares

$138 Million
0.07% of portfolio

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.93B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Account